SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-12-125674
Filing Date
2012-03-21
Accepted
2012-03-21 17:13:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d317440ds3.htm S-3 358624
2 FORM OF INDENTURE d317440dex46.htm EX-4.6 292550
3 OPINION OF WHITE SUMMERS CAFFEE & JAMES, LLP d317440dex51.htm EX-5.1 19604
4 OPINION OF LATHAM & WATKINS LLP d317440dex52.htm EX-5.2 24964
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES d317440dex121.htm EX-12.1 38150
6 CONSENT OF KPMG LLP d317440dex231.htm EX-23.1 2041
7 GRAPHIC g317440g69s00.jpg GRAPHIC 6148
8 GRAPHIC g317440img.jpg GRAPHIC 4886
9 GRAPHIC g317440img001.jpg GRAPHIC 3041
  Complete submission text file 0001193125-12-125674.txt   756841
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-180258 | Film No.: 12706635
SIC: 2834 Pharmaceutical Preparations